Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Mediterranean Journal of Hematology and Infectious Diseases|January 15, 2020
Candidemia in Patients with Acute Leukemia: Analysis of 7 Years' Experience at a Single Center in ChinaXiaoyuan Gong, Mianzeng Yang, Dong Lin, et al.
Cancer|November 10, 2024
Risk stratification in the clinical application of minimal residual disease assessment in acute myeloid leukemiaCongxiao Zhang, Runxia Gu, Huijun Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 30, 2014
[Characteristics and treatment outcomes in 822 adult patients with acute myeloid leukemia:a single center experience]Dong Lin, Chunlin Zhou, Hui Wei, et al.
Plos One|July 6, 2017
The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemiaRunxia Gu, Hui Wei, Ying Wang, et al.
Blood Science (Baltimore, Md.)|May 14, 2024
The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/<i>FUS::ERG</i>Anli Lai, Wenbing Liu, Hui Wei, et al.
Blood|May 21, 2026
Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic LeukemiaXiaoyuan Gong, Yuntao Liu, Qiuyun Fang, et al.
Experimental Hematology|February 1, 2021
Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1-RUNX1T1Hui Wei, Xueou Liu, Ying Wang, et al.
Leukemia|June 30, 2025
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trialXiaoyuan Gong, Wenbing Liu, Yuntao Liu, et al.
Experimental Hematology & Oncology|September 17, 2021
Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specifiedKaiqi Liu, Yan Li, Shaowei Qiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2020
Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid LeukemiaHui Wei, Ying Wang, Robert Peter Gale, et al.
Pageof 4